Voyager Therapeutics, Inc. (VYGR)
2.175
-0.10
(-4.19%)
USD |
NASDAQ |
Oct 13, 11:22
Voyager Therapeutics Price to Book Value : 0.8633 for Oct. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 0.901 |
| October 09, 2026 | 0.9724 |
| October 08, 2026 | 0.9407 |
| October 07, 2026 | 0.9804 |
| October 06, 2026 | 0.9764 |
| October 05, 2026 | 0.9764 |
| October 02, 2026 | 0.9724 |
| October 01, 2026 | 1.062 |
| September 30, 2026 | 1.064 |
| September 29, 2026 | 1.048 |
| September 28, 2026 | 1.072 |
| September 25, 2026 | 1.064 |
| September 24, 2026 | 1.111 |
| September 23, 2026 | 1.139 |
| September 22, 2026 | 1.246 |
| September 21, 2026 | 1.222 |
| September 18, 2026 | 1.226 |
| September 17, 2026 | 1.207 |
| September 16, 2026 | 1.211 |
| September 15, 2026 | 1.226 |
| September 14, 2026 | 1.266 |
| September 11, 2026 | 1.266 |
| September 10, 2026 | 1.266 |
| September 09, 2026 | 1.290 |
| September 08, 2026 | 1.350 |
| Date | Value |
|---|---|
| September 04, 2026 | 1.393 |
| September 03, 2026 | 1.342 |
| September 02, 2026 | 1.405 |
| September 01, 2026 | 1.361 |
| August 31, 2026 | 1.369 |
| August 28, 2026 | 1.405 |
| August 27, 2026 | 1.373 |
| August 26, 2026 | 1.373 |
| August 25, 2026 | 1.381 |
| August 24, 2026 | 1.365 |
| August 21, 2026 | 1.346 |
| August 20, 2026 | 1.318 |
| August 19, 2026 | 1.354 |
| August 18, 2026 | 1.310 |
| August 17, 2026 | 1.282 |
| August 14, 2026 | 1.298 |
| August 13, 2026 | 1.278 |
| August 12, 2026 | 1.270 |
| August 11, 2026 | 1.270 |
| August 10, 2026 | 1.258 |
| August 07, 2026 | 1.298 |
| August 06, 2026 | 1.242 |
| August 05, 2026 | 1.230 |
| August 04, 2026 | 1.240 |
| August 03, 2026 | 1.191 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 19.28 |
| Anika Therapeutics, Inc. | 2.001 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.170 |
Price to Book Value Related Metrics
| PS Ratio | 3.752 |
| Price | 2.175 |
| Earnings Yield | -83.37% |
| Market Cap | 133.27M |